Page 2 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

United statesAakash patelNovo nordiskGardy healthAnnual scientific sessionAmerican collegeCardiovascular outcomesPeople with overweightHeart failureProjected marketPharma analystHeart failureClinical trial

Urgent need for improved osteoporosis management to enhance patient outcomes: GlobalData

Urgent need for improved osteoporosis management to enhance patient outcomes: GlobalData
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Sulayman patelVishal lathwalAutism awareness dayPharma analyst

Weight management awareness essential to combat obesity crisis in India

Weight management awareness essential to combat obesity crisis in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Kapil devEli lilly zepboundNovo nordisk wegovyAbbott leptosSrija chilamulaPartnership weightofdiabetesGlobaldata pharmaceutical intelligence centerNovo nordiskPharmaceutical intelligence centerEli lillyPharma analystDigital marketing intelligence

Exclusive Oncology Deals In China Account For 41% Of Overall Deals In Past Five Years, Reveals GlobalData

Exclusive Oncology Deals In China Account For 41% Of Overall Deals In Past Five Years, Reveals GlobalData
mondovisione.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondovisione.com Daily Mail and Mail on Sunday newspapers.

South koreaNelluri geethaGlobaldata pharmaceutical intelligence center deals databasePharmaceutical intelligence center deals databasePharma analystTakeda pharmaceuticalHutchmed china

GlobalData : New wave of potential therapies to bring paradigm shift in COPD treatment, says GlobalData -March 25, 2024 at 11:38 pm EDT

25 Mar, 2024 New wave of potential therapies to bring paradigm shift in COPD treatment, says GlobalData Share Print page .

Sanofi regeneronSanofi regeneron dupixentVerona ensifentrineDrug administrationPharma analystBiologics license applicationOpinion leaders